Form 8-K - Current report:
SEC Accession No. 0001193125-24-273406
Filing Date
2024-12-09
Accepted
2024-12-09 16:10:00
Documents
16
Period of Report
2024-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d878105d8k.htm   iXBRL 8-K 34076
2 EX-10.1 d878105dex101.htm EX-10.1 25774
3 EX-10.2 d878105dex102.htm EX-10.2 3993
7 GRAPHIC g878105g1207001426006.jpg GRAPHIC 2659
  Complete submission text file 0001193125-24-273406.txt   203691

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrca-20241204.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20241204_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20241204_pre.xml EX-101.PRE 11262
18 EXTRACTED XBRL INSTANCE DOCUMENT d878105d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 241535192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)